[Characteristic features of the hormonal status of patients with exogenous constitutional obesity before and after nalorphine administration].
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D004723:Endorphins / Q000378:metabolism; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D008297:Male; D009269:Nalorphine / Q000494:pharmacology; D009765:Obesity / Q000503:physiopathology*; D011388:Prolactin / Q000378:metabolism; D011863:Radioimmunoassay; D013972:Thyrotropin / Q000378:metabolism; D013997:Time Factors; D001615:beta-Endorphin
D004723:Endorphins; D001615:beta-Endorphin; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D013972:Thyrotropin; D009269:Nalorphine; D006854:Hydrocortisone
Osobennosti gormonal'nogo statusa bol'nykh ékzogenno-konstitutsionnymozhireniem do i posle vvedeniia nalorfina.